Web Stats Provided By Google Analytics

Wednesday, August 28, 2013

Rexahn Pharmaceuticals Announces Teva will not Exercise its Option to License RX-3117

Rexahn Pharmaceuticals announced today that Teva Pharmaceutical Industries has decided, for strategic reasons, not to exercise its option to license RX-3117 from Rexahn.

http://www.pressreleasepoint.com/rexahn-pharmaceuticals-announces-teva-will-not-exercise-its-option-license-rx-3117

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts